LONP1 and metabolic syndrome: Further studies will allow us to determine the specific role of Lonp1 in the pathogenesis of each of the components of the metabolic syndrome (and their combination) and to develop drugs based on the Lonp1 protease, similar to the described new anticancer drugs targeting AAA + proteases [169].